Vaccine
GAVI vaccine group call for $7.5 billion funding
May 20, 2014Medical Communications, Sales and Marketing GAVI Alliance, Vaccine, WHO, rotavirus vaccine
The GAVI Alliance is calling on donors to back ambitious plans to immunise an additional 300 million children against potentially …
Lung cancer vaccine dropped
April 2, 2014Research and Development, Sales and Marketing GSK, MAGE-A3, NSCLC, Vaccine, lung cancer, magrit
GlaxoSmithKline took a hit today after its lung cancer vaccine MAGE-A3 failed to benefit patients. The London-based firm has now …
Novartis pays out for US biotech
February 17, 2014Research and Development, Sales and Marketing Cancer, Novartis, Vaccine, costim pharmaceuticals
Novartis is looking to shore up its cancer immunotherapy pipeline with the purchase of oncology specialist CoStim Pharmaceuticals. The Cambridge, …
World’s first Alzheimer’s vaccine trial begins
January 10, 2014Research and Development, Sales and Marketing AC Immune, ACI-35, Alzheimer's, Vaccine
AC Immune, a privately-held biotech based in Switzerland, has launched the world’s first trial of a vaccine against a protein …
GAVI begins roll-out of cheap HPV vaccine
October 17, 2013Sales and Marketing GAVI, HPV, Vaccine
For the first time women in parts of the world with the highest cervical cancer death rate will be able …
GSK sets malaria vaccine roll-out date to 2015
October 8, 2013Research and Development, Sales and Marketing GSK, Vaccine, malaria, rts, s
GlaxoSmithKline says it is just two years away from marketing the world’s first malaria vaccine RTS,S. This follows results from …
Calls to end UK anti-vaccine magazine
October 2, 2013Medical Communications, Sales and Marketing Cancer, Vaccine, sense about science
British retailers like Tesco and WH Smiths are being urged to drop an anti-vaccine magazine as it could be dangerous …
Sanaria’s malaria vaccine shows promise
August 9, 2013Research and Development, Sales and Marketing PfSPZ, Vaccine, malaria, sanaria
Researchers in the US have announced promising results from a Phase I clinical trial of biotech firm Sanaria’s new malaria …
Bayer signs cancer vaccine research deal
August 6, 2013Research and Development, Sales and Marketing Bayer, Vaccine, compugen
Bayer has entered into a new collaboration with Compugen to develop cancer vaccines aimed at helping the body fight off …
UK rejects meningitis B vaccine Bexsero
July 25, 2013Sales and Marketing Bexsero, Novartis, Vaccine, meningitis b
The UK government’s department for vaccinations has stunned observers by failing to back the world’s only vaccine for meningitis B. …
Diabetes vaccine trial posts positive results
June 28, 2013Research and Development, Sales and Marketing TOL-3021, Vaccine, diabetes
A groundbreaking new study suggests that the body’s immune system can be taught to reverse the effects of type 1 …
FDA delays GSK flu vaccine
March 27, 2013Research and Development, Sales and Marketing FDA, GSK, Vaccine
The FDA has cooled on GlaxoSmithKline’s latest vaccine for a bird flu pandemic, Q-Pan H5N1, despite a vote of confidence …
Vaccine manufacturing emerges as outsourcing market
January 28, 2013Manufacturing and Production R&D, Vaccine, outsourcing
Healthy growth in the market for vaccines – coupled with high production costs – look set to create a vaccine …
Setback for Sanofi dengue vaccine
September 13, 2012Research and Development, Sales and Marketing Dengue fever, Sanofi, Sanofi Pasteur, Vaccine
Sanofi Pasteur’s vaccine for dengue fever has failed to show protection against a key serotype of the potentially fatal illness. …
immatics’ vaccine increases survival in kidney cancer
July 30, 2012Research and Development, Sales and Marketing IMA901, Vaccine, Yervoy, immatics, phase III
immatics’ investigational cancer vaccine has increased survival rates in patients with renal cell carcinoma. In a late-stage trial, the German …
Latest content
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
